stjorthotic Chapter 621: You just need to do your job
Chapter 621: You just need to do your job
Chapter 621: You just need to do your job and there will be a surprise. Click to unlock now.
That evening, Huang Xiaochuan invited Ding Yi to his home in Mid-Levels. The two of them raised their glasses to the moon on the terrace facing Victoria Harbour, making a trio of people.
The two drank and chatted until dawn.
Ding Yi glanced at the beer bottles scattered on the ground, wiped his mouth, and said, "Alright, I've eaten, I've drunk, and I've successfully completed my mission. I'm going back now."
Huang Xiaochuan asked in surprise, "Why are you in such a hurry to go back? You haven't slept all night. Get some sleep, and I'll arrange a plane to take you back this afternoon."
Ding Yi waved his hand: "Just arrange a car to take me to the airport. You don't need to worry about anything else. If I want to sleep, I might as well sleep on the plane. I'll be home in no time. It won't delay anything."
Seeing this, Huang Xiaochuan stopped insisting: "Fine! Whatever you want!"
Ding arrived in a hurry and left in a hurry; before nine o'clock in the morning, he boarded a plane back to Shanghai.
The day after Ding Yi left, Xie Xinyue, after thoroughly investigating the current situation of Yi'e Kerui Pharmaceutical, went to the headquarters of Dadao Group to meet Huang Xiaochuan.
There was a knock on Huang Xiaochuan's office door. After the door opened, Gao Song led Xie Xinyue in.
"Sister Xie!" Upon seeing Xie Xinyue, Huang Xiaochuan stood up from his chair and went forward to greet her.
After looking around the office, Xie Xinyue joked, "Boss Huang, the view from your office is absolutely unbeatable."
Huang Xiaochuan then asked, "How's it going? Everything at home is arranged, right? Brother-in-law doesn't have any objections, does he? How's the accommodation? If you don't like it, I can rearrange it for you."
"Don't worry about such a small thing, everything is fine, I'm very satisfied with the house." Xie Xinyue waved her hand after sitting down.
At this moment, Gao Song brought in the coffee. After taking the coffee, Xie Xinyue got straight to the point: "To be honest, the conditions at Kerui Pharmaceuticals are much worse than Roche's R&D center. The laboratory equipment is too old. But these are not problems. I have learned about Kerui Pharmaceuticals' existing R&D departments, personnel and projects under development in the past few days. Apart from the pharmaceutical production line being quite good, the R&D aspect really needs a major overhaul."
Huang Xiaochuan nodded; this was indeed the current situation of Kerui Pharmaceuticals.
He said, "Back in Boston, I said that Corey's main strength lies in manufacturing, which is why we invited you, a top expert, to lead the research and development work."
Hearing Huang Xiaochuan say this, Xie Xinyue put down her coffee cup: "Xiaochuan, you promised, money is not a problem, that's why I came to rely on you."
Huang Xiaochuan smiled and said, "Sister Xie, don't worry about it! You don't need to worry about the R&D budget. What we need now is your feasible solutions."
Xie Xinyue had been waiting for Huang Xiaochuan to say this. She then took out a thick document from her briefcase: "This is a draft plan for the R&D center that I prepared after inspecting Kerui Pharmaceuticals. It was done in a hurry and the details are not yet perfect, but the general direction is clear."
Huang Xiaochuan listened attentively and gestured for Xie Xinyue to continue.
"The R&D center needs to be located in a relatively independent location. I think the Dapu Science Park is a good choice. The environment there is relatively quiet, the infrastructure is very complete, and it is also convenient to attract talents."
As for the construction standards of the R&D center laboratories, they must be constructed in strict accordance with internationally accepted standards, especially the core laboratories, animal breeding rooms, and biosafety laboratories. These are crucial factors in whether the drug data we develop in the future can be recognized internationally.
Based on the current situation, I plan to first establish a core team of no more than ten people, comprehensively covering major areas such as medicinal chemistry, pharmacology and toxicology, preclinical research, and intellectual property rights. These individuals must all have extensive experience in top international pharmaceutical companies or leading academic institutions, and they must be Chinese or of Chinese descent. I have already identified several suitable candidates, including some old acquaintances from Pfizer and Merck, and one person who is doing target research at the Max Planck Institute in Germany, who has great potential. However, poaching these individuals will be very costly and difficult.
Xie Xinyue kept looking at Huang Xiaochuan as she spoke.
Huang Xiaochuan waved his hand without hesitation: "That's no problem. Go ahead and invite them. I'll take care of all the funding you need."
After hearing Huang Xiaochuan's clear statement, Xie Xinyue continued, "I plan to rely on this team to recruit mid-to-senior level R&D personnel globally. The initial goal is to build an elite R&D team of about two hundred people within three years."
I also plan to establish long-term collaborations with local universities in Hong Kong and top medical schools in mainland China, which will not only cultivate future talent but also serve as joint experimental units for our product research and development.
However, I think we shouldn't expand too much at the beginning. After all, we're starting from scratch and don't have a certain level of technical expertise. We need time to integrate the team.
Therefore, considering the current situation and manufacturing foundation of Kerui Pharmaceuticals, as well as the characteristics of diseases in China, I will initially focus on three areas: oncology, metabolic diseases, and anti-infectives. These three areas have huge markets, urgent clinical needs, and are areas I am familiar with, so I plan to start with these three areas.
Next, I'm going to talk to you about the most expensive part. You may not be familiar with these technical terms, but I'll give you a general overview of the main uses of these devices.
We need high-content screening systems, high-throughput sequencers, mass spectrometers, nuclear magnetic resonance spectrometers, cryo-electron microscopes, and animal laboratories that meet AAAAC standards. These devices are fundamental to drug development and are indispensable. I've roughly estimated that the initial budget for purchasing and setting up these equipment platforms exceeds one hundred million US dollars, and the subsequent maintenance, upgrades, and consumables will require continuous investment.
Huang Xiaochuan nodded: "All of what you said is fine." Huang Xiaochuan agreed without even blinking when he heard that the cost was so low. In his mind, the first three-year budget he prepared for this R&D center was three billion US dollars.
Reassured, Xie Xinyue put down the documents in her hand and said, "I agree with choosing Hong Kong as the location. Hong Kong's legal and financial system is in line with international standards, and its intellectual property protection is very comprehensive. It will also facilitate our future international cooperation, technology introduction, patent layout, and possible overseas licensing. Talent introduction is also relatively flexible."
Moreover, backed by the vast patient population of mainland China, which is a valuable resource for clinical trials, and with the significant progress made in basic research in mainland China in recent years, we can collaborate with mainland research institutions to accelerate the translation of research findings. Furthermore, these findings, through Kerui Pharmaceuticals' plan to acquire and integrate pharmaceutical manufacturing plants in mainland China, can be rapidly transformed into production capacity to supply domestic and international markets.
Although Huang Xiaochuan didn't fully understand most of the technical terms, he had arranged for someone to conduct a comprehensive background check on Xie Xinyue. She was a well-known pharmaceutical research expert in the industry, and her character was excellent in every way. That's why Huang Xiaochuan finally decided to do this.
He looked at Xie Xinyue solemnly and said, "Just go ahead and do it. Money, people, materials—all the resources you need are not a problem. You just need to tell me what you need, and then you don't have to worry about it. Just focus on your research and development work."
After saying that, Huang Xiaochuan pressed the intercom on the table: "Gao Song, have Cao Charlie come over here for a moment!"
"Okay, Mr. Huang!" Gao Song replied crisply.